Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4153 Target Snapshot

Sigma non-opioid intracellular receptor 1 · SINGLE PROTEIN · Cavia porcellus

3,019Compounds
308Assays
13Approved Drugs
3,406.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q60492. Use UniProt Q60492 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q60492 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Sigma non-opioid intracellular receptor 1 as ChEMBL target CHEMBL4153, mapped to UniProt Q60492. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Sigma non-opioid intracellular receptor 1
SINGLE PROTEIN · Cavia porcellus
As of 2026-09-13
ChEMBL target ID
CHEMBL4153
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q60492
Sigma non-opioid intracellular receptor 1
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Sigma non-opioid intracellular receptor 1 is the right protein anchor across sources, using UniProt Q60492 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelSigma non-opioid intracellular receptor 1
UniProt AccessionQ60492
Component TypeProtein
Sequence Length223 aa

Sigma non-opioid intracellular receptor 1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Sigma non-opioid intracellular receptor 1, mapped to UniProt Q60492. Sequence length is 223 aa.

Mapped IDQ60492
Review nameSigma non-opioid intracellular receptor 1
OrganismCavia porcellus
Clinical Profile

Clinical Phase Distribution

13
Approved
1
Phase III
8
Phase II
Assay Mix

Activity Type Distribution

IC5022.0
KI3,382.0
KD2.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL372700 10.96 Ki 0.011 Preclinical
CHEMBL545278 10.52 Ki 0.03 Preclinical
CHEMBL176941 10.52 Ki 0.03 Preclinical
CHEMBL76758 10.44 Ki 0.036 Preclinical
CHEMBL1917286 10.3 Ki 0.05 Preclinical
CHEMBL304079 10.15 Ki 0.07 Preclinical
CHEMBL4073530 10.1 Ki 0.08 Preclinical
CHEMBL2069863 10.0 Ki 0.1 Preclinical
CHEMBL573234 9.96 Ki 0.11 Preclinical
CHEMBL2069865 9.92 Ki 0.12 Preclinical
Distribution

pChEMBL Value Distribution

93
5.0
193
5.5
328
6.0
455
6.5
517
7.0
466
7.5
491
8.0
343
8.5
151
9.0
36
9.5
pChEMBL
Approved Drugs

Approved Drugs

PITOLISANT
CHEMBL462605
Approved 2016
DOLUTEGRAVIR
CHEMBL1229211
Approved 2013
DONEPEZIL
CHEMBL502
Approved 1996
DEXTROMETHORPHAN
CHEMBL52440
Approved 1982
PROGESTERONE
CHEMBL103
Approved 1976
HALOPERIDOL
CHEMBL54
Approved 1967
PENTAZOCINE
CHEMBL100116
Approved 1967
Assay Landscape

Assay Landscape

308
Total Assays
2,683
Tested Compounds
2
Assay Types
Binding — 306 assays, 2,683 compounds
BAO Format Assays Compounds Avg pChEMBL
cell membrane format 200 1,689 7.4
assay format 55 745 7.3
single protein format 25 56 7.1
tissue-based format 24 192 7.2
microsome format 2 1 11.0
ADME — 2 assays, 23 compounds
BAO Format Assays Compounds Avg pChEMBL
cell membrane format 1 22 6.7
single protein format 1 1 5.7

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine